An Exploratory Investigation of a Novel Skincare Regimen

August 24, 2022 updated by: Trophy Skin
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Santa Monica, California, United States, 90404
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
  • Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin)
  • May experience hyperpigmentation and/or dark spots
  • In good general health
  • Willing to follow the study protocol skincare routine
  • Willing and able to share feedback and take skin pictures via the technology portal
  • Discontinue use of any alpha-hydroxy acids (AHAs) or over the counter exfoliating, polishing, or peeling topical skincare treatments 1 week before and for the duration of the study.

Exclusion Criteria:

  • Anyone with a diagnosed skin condition on their face
  • Use of prescription medication relevant to the skin
  • Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments
  • Use of oral acne treatment (e.g., Accutane)
  • Severe chronic conditions, including oncological conditions or psychiatric disorders.
  • Is pregnant, attempting pregnancy, or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aria Trio complete Facial System
Skincare system targetting wrinkles, pore size, sun spots, and overall skin quality.
Other: Aria Trio complete Facial System
Renew Serum, Brighten Serum, and Refine Serum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Time Frame: 4 weeks
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
Time Frame: 4 weeks
Participants will be given surveys at three timepoints so that they can assess the effectiveness of the product over the 4-week trial period
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Trophy Skin

Collaborators

Citruslabs

Investigators

  • Principal Investigator: Christopher Hill, PhD, Citruslabs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2022

Primary Completion (Actual)

July 1, 2022

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

August 24, 2022

First Submitted That Met QC Criteria

August 24, 2022

First Posted (Actual)

August 26, 2022

Study Record Updates

Last Update Posted (Actual)

August 26, 2022

Last Update Submitted That Met QC Criteria

August 24, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20245

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe